Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Neoplasms 2Radiation Injuries 1Prostatic Neoplasms 1Neoplasms, Second Primary 1Lung Neoplasms 1Head and Neck Neoplasms 1Eye Diseases 1Colorectal Neoplasms 1Cognitive Dysfunction 1Cardiovascular Diseases 1

Interventions

Radiotherapy 24Radiotherapy, Intensity-Modulated 8Radiosurgery 6Amifostine 5Low-Level Light Therapy 4Donepezil 4Cisplatin 4Carboplatin 4Surveys and Questionnaires 3Radiation 3Proton Therapy 3Paclitaxel 3Neuropsychological Tests 3Heavy Ion Radiotherapy 3Etoposide 3Chemotherapy, Adjuvant 3Chemoradiotherapy 3Brachytherapy 3Bevacizumab 3Surgical Procedures, Operative 2Radiation Dose Hypofractionation 2Patient Reported Outcome Measures 2Mental Status and Dementia Tests 2Esophagectomy 2Androgen Antagonists 2Adrenal Cortex Hormones 2sodium propionate 1sargramostim 1olaparib 1endostar protein 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Radiation Injuries × beta Carotene × Clear all
NCT00169845 2018-03-14

Beta-carotene and Alpha-tocopherol Chemoprevention of Second Primary Malignancies in Head and Neck Cancer Patients

Laval University

Phase 3 Completed
540 enrolled
Head & Neck

Head and Neck Neoplasms, Neoplasms, Radiation Injuries, Neoplasms, Second Primary

Data powered by HemOnc (CC BY 4.0) Colophon âš¡